Technical Analysis for ZBIO - Zenas BioPharma, Inc.

Grade Last Price % Change Price Change
F 7.71 -1.78% -0.14
ZBIO closed down 1.78 percent on Friday, February 7, 2025, on 71 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish -1.78%
NR7 Range Contraction -1.78%
Narrow Range Bar Range Contraction -1.78%
Wide Bands Range Expansion -1.78%
20 DMA Resistance Bearish -2.65%
Outside Day Range Expansion -2.65%
Wide Bands Range Expansion -2.65%
NR7 Range Contraction 0.65%
Inside Day Range Contraction 0.65%

   Recent Intraday Alerts

Alert Time
10 DMA Support 2 days ago
Down 5% 2 days ago
60 Minute Opening Range Breakdown 2 days ago
Up 1% 2 days ago
Down 3% 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Zenas BioPharma, Inc. Description

Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody for various indications, including immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. The company also develops ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Zenas BioPharma, Inc. was formerly known as Zenas BioPharma (Cayman) Limited and changed its name to Zenas BioPharma, Inc. in August 2023. The company was incorporated in 2019 and is based in Waltham, Massachusetts


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Immune System Antibodies Monoclonal Antibody Multiple Sclerosis Glycoproteins Systemic Lupus Erythematosus Immunoglobulin E Warm Autoimmune Hemolytic Anemia

Is ZBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 26.2508
52 Week Low 5.83
Average Volume 292,505
200-Day Moving Average 0.00
50-Day Moving Average 9.06
20-Day Moving Average 7.77
10-Day Moving Average 7.46
Average True Range 0.81
RSI (14) 43.82
ADX 26.36
+DI 18.56
-DI 26.39
Chandelier Exit (Long, 3 ATRs) 8.18
Chandelier Exit (Short, 3 ATRs) 8.25
Upper Bollinger Bands 8.77
Lower Bollinger Band 6.78
Percent B (%b) 0.47
BandWidth 25.56
MACD Line -0.54
MACD Signal Line -0.71
MACD Histogram 0.1641
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.39
Resistance 3 (R3) 8.37 8.13 8.28
Resistance 2 (R2) 8.13 7.96 8.14 8.24
Resistance 1 (R1) 7.92 7.85 7.80 7.94 8.20
Pivot Point 7.68 7.68 7.62 7.69 7.68
Support 1 (S1) 7.47 7.51 7.35 7.48 7.22
Support 2 (S2) 7.23 7.40 7.23 7.18
Support 3 (S3) 7.01 7.23 7.14
Support 4 (S4) 7.03